Related Experiment Video

Updated: Jun 27, 2026

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases
13:18

How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases

Published on: September 20, 2016

The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer

Hui Shen1, Nathan Powers, Nitin Saini

  • 1Department of Cell and Cancer Biology, University of Cincinnati, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.

Cancer Research
|December 17, 2008
PubMed

Insights

The Brm ATPase, crucial for prostate health, prevents cancer progression. Its loss in prostate cancer leads to uncontrolled cell growth, even without androgens, highlighting Brm as a key therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Biology

Background:

  • Prostate cancer progression factors are poorly understood, limiting new therapies.
  • Current treatments target androgen signaling, but resistance develops.
  • The role of Brm ATPase in prostate cancer is largely undefined.

Purpose of the Study:

  • To investigate the role of Brm ATPase in prostate cancer development and progression.
  • To determine if Brm loss contributes to castration-resistant prostate cancer.
  • To explore the therapeutic potential of targeting Brm in prostate cancer.

Main Methods:

  • Targeted gene ablation of Brm in mouse models.
  • In vivo analysis of prostatic hyperplasia and castration-resistant proliferation.
  • Analysis of Brm mRNA and protein levels in human prostate cancer specimens.
  • Gene expression profiling and E2F1 pathway analysis.

Main Results:

  • Brm ablation caused prostatic hyperplasia in mice.
  • Brm-deficient epithelia exhibited castration-resistant proliferation.
  • Brm mRNA and protein levels were reduced in human prostate cancer.
  • Brm loss correlated with increased proliferation and E2F1 deregulation.

Conclusions:

  • Brm ATPase acts as a tumor suppressor in the prostate.
  • Loss of Brm promotes prostate cancer progression and castration resistance.
  • Brm is a critical regulator of androgen-induced proliferation disrupted in prostate cancer.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...